Literature DB >> 6434132

Organisation of a programme for cervical cancer screening. ICRF coordinating committee on cervical screening.

.   

Abstract

Entities:  

Mesh：

Year:  1984        PMID： 6434132      PMCID： PMC1443451          DOI： 10.1136/bmj.289.6449.894

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Screening for cervical cancer: revised policy. The recommendations of the DHSS Committee on Gynaecological Cytology.

Authors:  G J Draper
Journal:  Health Trends       Date:  1982-05

2.  The role of cervical cytology in the declining morbidity and mortality of cervical cancer.

Authors:  D W Cramer
Journal:  Cancer       Date:  1974-12       Impact factor: 6.860

3.  Regional trends in incidence of cervical cancer in Denmark in relation to local smear-taking activity.

Authors:  E Lynge
Journal:  Int J Epidemiol       Date:  1983-12       Impact factor: 7.196

4.  Mortality from carcinoma of cervix uteri in Britain.

Authors:  J E Macgregor; S Teper
Journal:  Lancet       Date:  1978-10-07       Impact factor: 79.321
  4 in total
  5 in total

1.  Screening and mortality from cervical cancer. Does screening really reduce mortality?

Authors:  J S Vaidya; M Baum
Journal:  BMJ       Date:  1999-09-04

2.  Cancer of the cervix and the papilloma viruses.

Authors:  E G Knox; H S Shannon
Journal:  Eur J Epidemiol       Date:  1988-03       Impact factor: 8.082

3.  The role of the cancer registry in cancer control.

Authors:  B K Armstrong
Journal:  Cancer Causes Control       Date:  1992-11       Impact factor: 2.506

4.  Towards equity in organised cancer screening: the case of cervical cancer screening in France.

Authors:  Sylviane Darquy; Grégoire Moutel; Odile Jullian; Stéphanie Barré; Nathalie Duchange
Journal:  BMC Womens Health       Date:  2018-11-26       Impact factor: 2.809

5.  An international consensus on the essential and desirable criteria for an 'organized' cancer screening programme.

Authors:  Li Zhang; André L Carvalho; Isabel Mosquera; Tianmeng Wen; Eric Lucas; Catherine Sauvaget; Richard Muwonge; Marc Arbyn; Elisabete Weiderpass; Partha Basu
Journal:  BMC Med       Date:  2022-03-23       Impact factor: 8.775
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.